Catalyst Funds Management Pty LTD Tandem Diabetes Care Inc Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 300 shares of TNDM stock, worth $11,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$11,211% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNDM
# of Institutions
360Shares Held
72.2MCall Options Held
3.36MPut Options Held
229K-
Black Rock Inc. New York, NY11.1MShares$416 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.36MShares$275 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.27MShares$122 Million0.02% of portfolio
-
State Street Corp Boston, MA2.66MShares$99.2 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.39MShares$89.2 Million1.44% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.4B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...